Skip to Main Content

Paper Details

Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer.
Oncogene
6
2022
/, ATR, BRCA2, BRCA2-mutant PEO1 cells, CHK1, EZH2, MUS81, OlaJR, OlaR, PARP, PARPi, PARPis, PEO1, Poly (ADP-ribose), Poly (ADP-ribose) polymerase, mesenchymal, ovarian cancer, patients

Datasets

Release 1.2